# OnCo record ikena-oncology (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/ikena-oncology/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "ikena-oncology" ;
  schema:name "Ikena Oncology"@en ;
  schema:alternateName "Ikena Oncology, Inc."@en, "ImageneBio, Inc."@en ;
  schema:description "Ikena Oncology developed targeted cancer drugs. In July 2025 it merged with Inmagene Biopharmaceuticals and renamed itself ImageneBio, which now works on an antibody for eczema rather than cancer."@en ;
  schema:url <https://onco.cc/companies/ikena-oncology/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1835579/000119312524283722/d889670dex991.htm>, <https://www.sec.gov/Archives/edgar/data/1835579/000119312525167089/d66290d8k.htm>, <https://imagenebio.com/>, <https://atlasventure.com/portfolio/> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> .